Abstract
Oncoprotein 18/stathmin (Op18) is a conserved cytosolic phosphoprotein that regulates microtubule dynamics. The microtubule destabilizing activity is regulated by phosphorylation, mediated by both growth factor stimulated- and cell-cycle regulating kinases. The protein is highly expressed in a variety of human malignancies. In human breast carcinoma, Op18 has previously been shown to be up-regulated in a subset of the tumours, however, no correlation with clinicopathologic characteristics has been reported so far. In the present study we have examined Op18 protein expression by quantitative Western blot analysis in a panel of 151 semi-consecutive breast carcinoma samples. Op18 levels were negatively correlated with oestrogen receptor (OR) expression and positively correlated with a high fraction of aneuploid cells, proliferation measured by proliferating cell nuclear antigen (PCNA) expression, tumour size and histopathologic grade. Taken together, and in contrast to what has been previously reported, the present study shows that high Op18 expression correlates with general predictive factors and is not restricted to a specific sub-group of breast carcinoma. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Ahn J, Murphy M, Kratowicz S, Wang A, Levine AJ and George DL (1999) Down regulation of the stathmin/Op18 and FKBP25 genes following p53 induction. Oncogene 18: 5954–5958
Balogh A, Mege RM Sobel A (1996) Cell density dependent expression of stathmin in C2 myoblasts in culture. Exp Cell Res 224: 8–15
Belmont LD Mitchison TJ (1996) Identification of a protein that interacts with tubulin dimers and increases the catastrophe rate of microtubules. Cell 84: 623–631
Beretta L, Dobransky T Sobel A (1993) Multiple phosphorylation of stathmin. Identification of four sites phosphorylated in intact cells and in vitro by cyclic AMP-dependent protein kinase and p34cdc2. J Biol Chem 268: 20076–20084
Bièche I, Lachkar S, Becette V, Cifuentes-Diaz C, Sobel A, Lidereau R Curmi PA (1998) Overexpression of the stathmin gene in a subset of human breast cancer. Br J Cancer 78: 701–709
Brattsand G, Roos G, Marklund U, Ueda H, Landberg G, Nånberg E, sideras P Gullberg M (1993) Quantitative analysis of the expression and regulation of an activation-regulated phosphoprotein (oncoprotein 18) in normal and neoplastic cells. Leukemia 7: 569–579
Brattsand G, Marklund U, Nylander K, Roos G Gullberg M (1994) Cell-cycle-regulated phosphorylation of oncoprotein 18 on Ser16, Ser25 and Ser 38. Eur J Biochem 220: 359–368
Burton K (1968) Determination of DNA concentrations with diphenylamine. In: Methods in enzymology 12, Grossman L and Moldave K (eds), pp. 163–166, Academic Press: New York
Cailleau R, Olivé M Cruciger QVJ (1978) Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization. In Vitro 14: 911–915
Caleffi M, Teague MW, Jensen RA, Vnencak-Jones CL, Dupont WD Parl FF (1994) P53 gene mutations and steroid receptor status in breast cancer. Cancer 73: 2147–2156
Cassimeris L (1999) Accessory protein regulation of microtubule dynamics throughout the cell cycle. Curr Opin Cell Biol 11: 134–141
Cooper HL, Fulder R, McDuffie E Braverman R (1990) A specific defect of prosolin phosphorylation in T cell leukemic lymphoblasts is associated with impaired down-regulation of DNA synthesis. J Immunol 145: 1205–1213
Doye V, Soubrier F, Bauw G, Boutterin MC, Beretta L, Koppel J, Vandekerckhove J Sobel A (1989) A single cDNA encodes two isoforms of stathmin, a developmentally regulated neuron-enriched phosphoprotein. J Biol Chem 264: 12134–12137
Elston CW Ellis IO (1991) Pathological prognostic factors in breast cancer, I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19: 403–410
Fechter GE, Mueller A, Kaufmann M, Haag D, Born IA, Abel U, Klinga K, Kubli F Goerttler K (1988) Correlation of DNA flow cytometric results and other prognostic factors in primary breast cancer. Int J Cancer 41: 823–828
Fogh J, Wright WC Loveless JD (1977) Absence of HeLa cell contamination in 169 cell lines derived from human tumours. J Natl Cancer Inst 58: 209–214
Friedrich B, Grönberg H, Landström M, Bergh A Gullberg M (1995) Differentiation-stage specific expression of oncoprotein 18 in human and rat prostatic adenocarcinoma. Prostate 27: 102–109
Ghosh PK, Anderson J, Cohen N, Takeshita K, Atweh GF Lebowitz P (1993) Expression of the leukemia-associated gene, p18, in normal and malignant tissues; inactivation of expression in a patient with cleaved B-cell lymphoma/leukemia. Oncogene 8: 2869–2872
Gullberg M, Noreus K, Brattsand G, Friedrich B Shingler V (1990) Purification and characterization of a 19-kilodalton intracellular protein. An activation-regulated putative protein kinase C substrate of T lymphocytes. J Biol Chem 265: 17499–17505
Hailat N, Strahler JR, Melhem RF, Zhu XX, Brodeur G, Seeger RC, Reynolds CP Hanash SM (1990) N-myc gene amplification in neuroblastoma isassociated with altered phosphorylation of a proliferation related polypeptide (Op18). Oncogene 5: 1615–1618
Hanash SM, Strahler JR, Kuick R, Chu EH Nichols D (1988) Identification of a polypeptide associated with the malignant phenotype in acute leukemia. J Biol Chem 263: 12813–12815
Jeha S, Luo X, Beran M, Kantarjian H Atweh GF (1996) Antisense RNA inhibition of phosphoprotein p18 expression abrogates the transformed phenotype of leukemic cells. Cancer Res 56: 1445–1450
Keydar I, Chen L, Karby S, Weiss FR, Delarea J, Radu M, Chaitcik S Brenner HJ (1979) Establishment and characterization of a cell line of human breast carcinoma origin. Eur J Cancer 15: 659–670
Koppel J, Loyer P, Maucuert A, Rehák P, Manceau V, Guguen-Guillouzo C Sobel A (1993) Induction of stathmin expression during liver regeneration. FEBS Lett 331: 65–70
Labdon JE, Nieves E Schubart UK (1992) Analysis of phosphoprotein p19 by liquid chromatography/mass spectrometry. Identification of two proline-directed serine phosphorylation sites and a blocked amino terminus. J Biol Chem 267: 3506–3513
Larsson N, Marklund U, Melander Gradin H, Brattsand G Gullberg M (1997) Control of microtubule dynamics by oncoprotein 18: Dissection of the regulatory role of multisite phosphorylation during mitosis. Mol Cell Biol 17: 5530–5539
Lawler S (1998) If you need a shrink try stathmin/Op18. Curr Biol 8: 212–214
Leighton IA, Curmi P, Campbell DG, Cohen P Sobel A (1993) The phosphorylation of stathmin by MAP kinase. Mol Cell Biochem 127–128: 151–156
Lengauer C, Kinzler KW Vogelstein B (1998) Genetic instabilities in human cancers. Nature 396: 643–649
Luo X, Mookerjee B, Ferrari A, Mistry S Atweh GF (1994) Regulation of phosphoprotein p18 in leukemic cells. Cell cycle regulated phosphorylation by p34cdc2kinase. J Biol Chem 269: 10312–10318
Marklund U, Brattsand G, Osterman O, Ohlsson PI Gullberg M (1993 a) Multiple signal transduction pathways induce phosphorylation of serine 16, 25, and 38 of oncoprotein 18 in T lymphocytes. J Biol Chem 268: 25671–25680
Marklund U, Brattsand G, Shingler V Gullberg M (1993 b) Serine 25 of oncoprotein 18 is a major cytosolic target for the mitogen-activated protein kinase. J Biol Chem 268: 15039–15047
Marklund U, Larsson N, Brattsand G, Osterman Ö, Chatila TA Gullberg M (1994) Serine 16 of oncoprotein 18 is a major cytosolic target for the Ca2+/calmodulin-dependent kinase-Gr. Eur J Biochem 225: 53–60
Marklund U, Larsson N, Melander Gradin H, Brattsand G Gullberg M (1996) Oncoprotein 18 is a phosphporylation-responsive regulator of microtubule dynamics. EMBO J 15: 5290–5298
McNally FJ (1999) Controlling split ends. Curr Biol 9: 274–276
Melander Gradin H, Marklund U, Larsson N, Chatila TA Gullberg M (1997) Regulation of microtubule dynamics by Ca2+/calmodulin-dependent kinase IV/Gr-dependent phosphorylation of oncoproten 18. Mol Cell Biol 17: 3459–3467
Melander Gradin H, Larsson N, Marklund H Gullberg M (1998) Regulation of Microtubule dynamics by extracellular signals: cAMP-dependent protein kinase switches off the activity of oncoprotein 18 in intact cells. J Cell Biol 140: 131–141
Meyer JS Province MA (1994) S-phase fraction and nuclear size in long term prognosis of patients with breast cancer. Cancer 74: 2287–2299
Murphy M, Ahn J, Walker KK, Hoffman WH, Evans RM, Levine AJ George DL (1999) Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a. Genes Dev 13: 2490–2501
Nielsen NH, Arnerlöv C, Emdin SO Landberg G (1996) Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to ostrogen receptor status. Br J Cancer 74: 874–880
Nylander K, Marklund U, Brattsand G, Gullberg M Roos G (1995) Immunohistochemical detection of oncoprotein 18 (Op18) in malignant lymphomas. Histochem J 27: 155–160
Roos G, Brattsand G, Landberg G, Marklund U Gullberg M (1993) Expression of oncoprotein 18 in human leukemias and lymphomas. Leukemia 7: 1538–1546
Sadler WA, Murray LM Turner JG (1992) Minimum distinguishable difference in concentration: A clinically oriented translation of assay precision summaries. Clin Chem 38: 1773–1778
Schubart UK, Banerjee MD Eng J (1989) Homology between the cDNAs encoding phosphoprotein p19 and SCG10 reveals a novel mammalian gene family preferentially expressed in developing brain. DNA 8: 389–398
Sigurdsson H, Baldetorp B, Borg Å, Dalberg M, Fernö M, Killander D Olsson H (1990) Indicators of prognosis in nod-negative breast cancer. N Engl J Med 322: 1045–1053
Sobel A (1991) Stathmin: a relay phosphoprotein for multiple signal transduction?. Trends Biochem Sci 16: 301–305
Soule HD, Vazquez J, Long A, Albert S Brennan M (1973) A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 21: 1409–1416
Vindelov LL, Christensen IJ Nissen NI (1983) A detergen-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3: 323–327
Zhang CC, Yang JM, White E, Murphy M, Levine A Hait WN (1998) The role of MAP4 expression in the sensitivity to paclitaxel and resistance to vinca alkaloids in p53 mutant cells. Oncogene 16: 1617–1624
Zhang CC, Yang JM, Bash-Babula J, White E, Murphy M, Levine AJ Hait NW (1999) DNA damage increases sensitivity to vinca alkaloids and decreases sensitivity to taxanes through p53-dependent repression of microtubule-associated protein 4. Cancer Res 59: 3663–3670
Zhu XX, Kozarsky K, Strahler JR, Eckerskorn C, Lottspeich F, Melhem R, Lowe J, Fox DA, Hanash SM Atweh GF (1989) Molecular cloning of a novel human leukemia-associated gene. Evidence of conservation in animal species. J Biol Chem 264: 14556–14560
Zimmerman W, Sparks CA Doxsey SJ (1999) Amorphous no longer: the centrosome comes into focus. Curr Opin Cell Biol 11: 122–128
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Brattsand, G. Correlation of oncoprotein 18/stathmin expression in human breast cancer with established prognostic factors. Br J Cancer 83, 311–318 (2000). https://doi.org/10.1054/bjoc.2000.1264
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2000.1264
Keywords
This article is cited by
-
HMGA1 positively regulates the microtubule-destabilizing protein stathmin promoting motility in TNBC cells and decreasing tumour sensitivity to paclitaxel
Cell Death & Disease (2022)
-
RETRACTED ARTICLE: STMN-1 is a potential marker of lymph node metastasis in distal esophageal adenocarcinomas and silencing its expression can reverse malignant phenotype of tumor cells
BMC Cancer (2014)
-
Overexpression of stathmin 1 confers an independent prognostic indicator in nasopharyngeal carcinoma
Tumor Biology (2014)
-
Anti-centrosome antibodies in breast cancer are the expression of autoimmunity
Immunologic Research (2014)
-
Lentiviral-mediated RNA interference targeting stathmin1 gene in human gastric cancer cells inhibits proliferation in vitro and tumor growth in vivo
Journal of Translational Medicine (2013)